-Shu-Guang Lin Researcher Activity Profile

Research Author Detailed Information 

Shu-Guang Lin Publication Rate By Year

Shu-Guang Lin has published 2 paper(s) in 2005, 1 paper(s) in 2006, 8 paper(s) in 2007, 5 paper(s) in 2008, for a total of 16 research publications in total.

Shu-Guang Sg Lin Author Information

LAST NAME: lin

FIRST NAME: Shu-guang

INITIALS: sg

AFFILIATION:

Papers

Shu-Guang Lin's Publication Record

1. [The development of a new perimenbranous ventricular septal defect occluder] Year Published: 2005
Department of Pediatrics, Guangdong Cardiovascular Institute, Guangdong 510100, China.
2. [The AGT genotype affects the antihypertensive effects of benazepril] Year Published: 2005
Guangdong Provincial Cardiovascular Institute, Guangzhou 510080, China.
3. [Association of the polymorphism of macrophage migration inhibitory factor gene with coronary heart disease in Chinese population] Year Published: 2006
Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Diseases Institute, Guangzhou, Guangdong, 510080 PR China. Zhixinshan@yahoo.com.cn
4. Macrophage migration inhibitory factor induces MMP-9 expression in macrophages via the MEK-ERK MAP kinase pathway. Year Published: 2007
The Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangzhou 510080, China.
5. [Study on the haplotypes of pfcrt polymorphism from Hainan Province] Year Published: 2007
Changzhou Center for Disease Prevention and Control, Changzhou 213003, China.
6. Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment. Year Published: 2007
Southern California Desert Retina Consultants, Palm Springs, CA 92263, USA. cchan@desertretina.com
7. A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies. Year Published: 2007
Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou 510080, People's Republic of China.
8. The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Year Published: 2007
Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, Guangdong, China.
9. Retinal pigment epithelial tear after ranibizumab therapy for subfoveal fibrovascular pigment epithelial detachment. Year Published: 2007
Southern California Desert Retina Consultants, Palm Springs, CA 92263, USA. cchan@desertretina.com
10. A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies. Year Published: 2007
Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangzhou 510080, People's Republic of China.
11. Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Year Published: 2008
1Department of Clinical Pharmacology, Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, Guangdong, China.
12. The novel peptide apelin regulates intrarenal artery tone in diabetic mice. Year Published: 2007
Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, Guangdong, China.
13. Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Year Published: 2008
14. Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Year Published: 2008
Department of Clinical Pharmacology, Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, Guangdong, China.
15. Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Year Published: 2008
Department of Clinical Pharmacology, Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, Guangdong, China.
16. Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression. Year Published: 2008
Department of Clinical Pharmacology, Research Center of Medical Sciences, Guangdong Provincial People's Hospital, Guangdong Provincial Cardiovascular Institute, Guangzhou, Guangdong, China. jiuchangzhong@yahoo.com.cn [corrected]